Peripheral blood abnormalities and bone marrow infiltration in canine large B-cell lymphoma: is there a link?

Official guidelines do not consider bone marrow (BM) assessment mandatory in staging canine lymphoma unless blood cytopenias are present. The aim of this study was to find out if blood abnormalities can predict marrow involvement in canine large B-cell lymphoma. BM infiltration was assessed via flow cytometry. No difference was found between dogs without haematological abnormalities and dogs with at least one. However, the degree of infiltration was significantly higher in dogs with thrombocytopenia, leucocytosis or lymphocytosis and was negatively correlated to platelet count and positively to blood infiltration. Our results suggest that blood abnormalities are not always predictive of marrow involvement, even if thrombocytopenia, leucocytosis or lymphocytosis could suggest a higher infiltration. BM evaluation should therefore be included in routine staging in order not to miss infiltrated samples and to improve classification. However, its clinical relevance and prognostic value are still not defined and further studies are needed.

[1]  N. Eberle,et al.  Flow cytometric evaluation of peripheral blood and bone marrow and fine-needle aspirate samples from multiple sites in dogs with multicentric lymphoma. , 2012, American journal of veterinary research.

[2]  Ming-Sun Yu,et al.  Prognostic value of platelet count in diffuse large B-cell lymphoma. , 2012, Clinical lymphoma, myeloma & leukemia.

[3]  Paul R. Avery,et al.  Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. , 2011, Journal of veterinary internal medicine.

[4]  M. Gelain,et al.  Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma. , 2011, Veterinary journal.

[5]  L. Marconato,et al.  Predictors of long-term survival in dogs with high-grade multicentric lymphoma. , 2011, Journal of the American Veterinary Medical Association.

[6]  J. Byrd,et al.  Non-Hodgkin's lymphomas. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[7]  C. Khanna,et al.  Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document. , 2010, Veterinary and comparative oncology.

[8]  B. Shadbolt,et al.  Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI) , 2009, Journal of hematology & oncology.

[9]  P. Morley,et al.  Anemia is associated with decreased survival time in dogs with lymphoma. , 2008, Journal of veterinary internal medicine.

[10]  L. Marconato,et al.  Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference? , 2008, Veterinary and comparative oncology.

[11]  Paul R. Avery,et al.  Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. , 2008, Journal of veterinary internal medicine.

[12]  M. Mazzilli,et al.  Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. , 2008, Veterinary immunology and immunopathology.

[13]  M. D. Lucroy,et al.  Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006). , 2007, Journal of the American Veterinary Medical Association.

[14]  H. Erb,et al.  Stage migration in dogs with lymphoma. , 2007, Journal of veterinary internal medicine.

[15]  K. Chalvet-Monfray,et al.  Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. , 2004, Veterinary journal.

[16]  A. Morávková,et al.  Flow cytometric analysis of bone marrow leukocytes in neonatal dogs. , 2003, Veterinary immunology and immunopathology.

[17]  T. Habermann,et al.  Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. , 1999, Blood.

[18]  M. Kiupel,et al.  Prognostic Factors for Treated Canine Malignant Lymphoma , 1999, Veterinary pathology.

[19]  E. Breitschwerdt,et al.  Immunophenotypic comparison of blood and lymph node from dogs with lymphoma. , 1998, Veterinary clinical pathology.